Propanc Biopharma, Inc. | Business Finance | Business Contracts

Note, dated November 3, 2022, issued to the Investor (Filed With SEC on May 15, 2023)

Securities Purchase Agreement, dated November 3, 2022, by and between the Company and the Investor (Filed With SEC on May 15, 2023)

Registration Rights Agreement, dated November 3, 2022, by and between the Company and the Investor (Filed With SEC on May 15, 2023)

Warrant Agreement, dated March 8, 2023, by and between the Company and the Warrant Holder (Filed With SEC on May 15, 2023)

10% Convertible Redeemable Note, dated February 14, 2023, issued by the Company to ONE44 Capital LLC (Filed With SEC on February 21, 2023)

Securities Purchase Agreement, dated February 14, 2023, by and between the Company and ONE44 Capital LLC (Filed With SEC on February 21, 2023)

8% Convertible Promissory Note, dated October 6, 2022, issued by the Company to Red Road Holdings Corporation (Filed With SEC on October 12, 2022)

Securities Purchase Agreement, dated October 6, 2022, by and between the Company and Red Road Holdings Corporation (Filed With SEC on October 12, 2022)

8% Convertible Redeemable Note, dated September 21, 2022, issued by the Company to GS Capital Partners, LLC (Filed With SEC on September 27, 2022)

Securities Purchase Agreement, dated September 21, 2022, by and between the Company and GS Capital Partners, LLC (Filed With SEC on September 27, 2022)

8% Convertible Redeemable Note, dated August 12, 2022, issued by the Company to GS Capital Partners, LLC (Filed With SEC on August 18, 2022)

10% Convertible Redeemable Note, dated August 15, 2022, issued by the Company to ONE44 Capital LLC (Filed With SEC on August 18, 2022)

Securities Purchase Agreement, dated August 12, 2022, by and between the Company and GS Capital Partners, LLC (Filed With SEC on August 18, 2022)

Securities Purchase Agreement, dated August 15, 2022, issued by the Company to ONE44 Capital LLC (Filed With SEC on August 18, 2022)

8% Convertible Promissory Note, dated June 30, 2022, issued by the Company to 1800 Diagonal Lending LLC (Filed With SEC on July 7, 2022)

Securities Purchase Agreement, dated June 30, 2022, by and between the Company and 1800 Diagonal Lending LLC (Filed With SEC on July 7, 2022)

8% Convertible Promissory Note, dated May 12, 2022, issued by the Company to 1800 Diagonal Lending LLC (Filed With SEC on May 18, 2022)

Securities Purchase Agreement, dated May 12, 2022, by and between the Company and 1800 Diagonal Lending LLC (Filed With SEC on May 18, 2022)

8% Convertible Promissory Note, dated April 12, 2022, issued by the Company to Sixth Street Lending LLC (Filed With SEC on April 18, 2022)

Securities Purchase Agreement, dated April 12, 2022, by and between the Company and Sixth Street Lending LLC (Filed With SEC on April 18, 2022)

10% Convertible Redeemable Note, dated March 29, 2022, issued by the Company to ONE44 Capital LLC (Filed With SEC on April 1, 2022)

Securities Purchase Agreement, dated March 29, 2022, by and between the Company and ONE44 Capital LLC (Filed With SEC on April 1, 2022)

8% Convertible Promissory Note, dated March 7, 2022, issued by the Company to Sixth Street Lending LLC (Filed With SEC on March 10, 2022)

Securities Purchase Agreement, dated March 7, 2022, by and between the Company and Sixth Street Lending LLC (Filed With SEC on March 10, 2022)

8% Convertible Promissory Note, January 3, 2022 (Filed With SEC on January 10, 2022)

Securities Purchase Agreement, dated January 3, 2022, by and between the Company and Sixth Street Lending LLC (Filed With SEC on January 10, 2022)

10% Convertible Promissory Note, dated December 7, 2021, issued by the Company to ONE44 Lending LLC (Filed With SEC on December 13, 2021)

Securities Purchase Agreement, dated December 7, 2021, by and between the Company and ONE44 Lending LLC (Filed With SEC on December 13, 2021)

Common Stock Purchase Agreement, by and between the Company and Dutchess Capital Growth Fund LP, dated November 30, 2021 (Filed With SEC on December 7, 2021)

Registration Rights Agreement, by and between the Company and Dutchess Capital Growth Fund LP, dated November 30, 2021 (Filed With SEC on December 7, 2021)

8% Convertible Promissory Note, dated November 26, 2021, issued by the Company to Sixth Street Lending LLC (Filed With SEC on December 1, 2021)

Securities Purchase Agreement, dated November 26, 2021, by and between the Company and Sixth Street Lending LLC (Filed With SEC on December 1, 2021)

8% Convertible Promissory Note, dated October 21, 2021, issued by the Company to Sixth Street Lending LLC (Filed With SEC on October 27, 2021)

Securities Purchase Agreement, dated October 21, 2021, by and between the Company and Sixth Street Lending LLC (Filed With SEC on October 27, 2021)

8% Convertible Promissory Note, dated September 22, 2021, issued by the Company to Geneva Roth Remark Holdings, Inc (Filed With SEC on September 28, 2021)

Securities Purchase Agreement, dated September 22, 2021, by and between the Company and Geneva Roth Remark Holdings, Inc (Filed With SEC on September 28, 2021)

8% Convertible Promissory Note, dated August 19, 2021, issued by the Company to Geneva Roth Remark Holdings, Inc (Filed With SEC on August 25, 2021)

Securities Purchase Agreement, dated August 19, 2021, by and between the Company and Geneva Roth Remark Holdings, Inc (Filed With SEC on August 25, 2021)

8% Convertible Promissory Note, dated March 16, 2021, issued by the Company to Geneva Roth Remark Holdings, Inc (Filed With SEC on March 19, 2021)

Securities Purchase Agreement, dated March 16, 2021, by and between the Company and Geneva Roth Remark Holdings, Inc (Filed With SEC on March 19, 2021)

Propanc Biopharma, Inc. (243) | Business Finance (78)